1-2 of 2
Alexandra G. Jacob, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013)

Craig H. Moskowitz, MD, Vincent Ribrag, MD, Jean-Marie Michot, MD, Giovanni Martinelli, MD, Pier Luigi Zinzani, MD, PhD, Martin Gutierrez, MD, Guadalupe De Maeyer, Alexandra G. Jacob, BS, Karen Giallella, Jennifer Weimer Anderson, Martha Derosier, Joy Wang, Zijiang Yang, Eric Rubin, MD, Shelonitda Rose, Margaret A. Shipp, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2014) 124 (21): 290.
https://doi.org/10.1182/blood.V124.21.290.290
Published: 2014
Journal Articles

Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Joachim Yahalom, MD, Heiko Schoder, MD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F. Gerecitano, MD PhD, Audrey Hamilton, MD, Paul Hamlin, MD, Steven M. Horwitz, MD, Alexandra G. Jacob, BS, Matthew J. Matasar, MD MS, Susan McCall, Alison J Moskowitz, MD, Ariela Noy, Lia Palomba, MD, Carol S Portlock, MD, David J. Straus, MD, Stephanie Verwys, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Anas Younes, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2014) 124 (21): 3085.
https://doi.org/10.1182/blood.V124.21.3085.3085
Published: 2014